Lucas Ferrari De Andrade, PhD

About Me

Dr. Ferrari de Andrade received his PhD in Cellular and Molecular Biology from Universidade Federal do Paraná, Brazil, in 2014. During this period, he also developed part of his Ph.D. for 12 months in the QIMR Berghofer Medical Research Institute, Australia. In 2014, right after obtaining his Ph.D., Dr. Ferrari de Andrade started his 5-years postdoctoral training in the Dana-Farber Cancer Institute / Harvard Medical School. In 2019, Dr. Ferrari de Andrade joined the Precision Immunology Institute in the Icahn School of Medicine at Mount Sinai, to start his own laboratory. Since then, his laboratory has been working to develop new immunotherapies for cancers.

Language

English

Position

ASSOCIATE PROFESSOR | Immunology & Immunotherapy, ASSOCIATE PROFESSOR | Oncological Sciences

Research Topics

Cancer, Immunology

Multi-Disciplinary Training Areas

Cancer Biology [CAB], Immunology [IMM]

Education

BSc / Lic, Universidade Federal do Parana

MSc, Universidade Federal do Parana

PhD, Universidade Federal do Parana

Visiting Student, QIMR Berghofer Medical Research Institute

Postdoc, Dana-Farber Cancer Institute

Research

Natural killer cells, as the name implies, are lymphocytes that kill aberrant cells such as the ones that undergo malignant transformation. However, cancers often develop because of, at least in parts, mechanisms of immune evasion. Our laboratory develops antibodies that restore the immune surveillance for transformed cells. We reason that such antibodies could serve as immunotherapeutics for a variety of cancers.

Visit the Ferrari de Andrade Laboratory

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Ferrari de Andrade during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

Ono Pharmaceuticals
Cullinan Oncology, LLC

Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.